For the first time, researchers have shown that an enzyme key to regulating gene expression — and also an oncogene when mutated — is critical for the expression of numerous inflammatory compounds that have been implicated in age-related increases in cancer and tissue degeneration. Inhibitors of the enzyme are being developed as a new anti-cancer target.